Risk factors for developing capsular contracture in women after breast implant surgery: A systematic review of the literature

2018 ◽  
Vol 71 (11) ◽  
pp. e68 ◽  
Author(s):  
Yara Bachour ◽  
Marco J.P.F. Ritt
2018 ◽  
Vol 71 (9) ◽  
pp. e29-e48 ◽  
Author(s):  
Yara Bachour ◽  
Claudia A. Bargon ◽  
Christel J.M. de Blok ◽  
Johannes C.F. Ket ◽  
Marco J.P.F. Ritt ◽  
...  

2001 ◽  
Vol 47 (4) ◽  
pp. 359-366 ◽  
Author(s):  
Kim Kj??ller ◽  
Lisbet R. H??lmich ◽  
Poul Harboe Jacobsen ◽  
S??ren Friis ◽  
Jon Fryzek ◽  
...  

2011 ◽  
Vol 26 (9) ◽  
pp. 1036-1049 ◽  
Author(s):  
Rita V. Patel ◽  
Michael L. Shelling ◽  
Srdjan Prodanovich ◽  
Daniel G. Federman ◽  
Robert S. Kirsner

2020 ◽  
Vol 000 (000) ◽  
pp. 1-7
Author(s):  
Chunmei Wang ◽  
Xiaozhong Guo ◽  
Yang An ◽  
Shixue Xu ◽  
Dan Zhang ◽  
...  

2018 ◽  
Vol 33 (4) ◽  
pp. 225-233 ◽  
Author(s):  
P Kern

Objective Telangiectasias of the lower legs are intradermal dilatations of the subpapillary venous plexus, but their pathophysiology and risk factors are still largely unknown. The purpose of this review is to summarize the current knowledge on the pathophysiology and risk factors for telangiectasias. Methods A systematic review of the literature indexed in Medline completed with textbooks and European phlebology journals from the French, Swiss, and German phlebology societies was performed. Results A multitude of risk factors and several pathophysiological hypotheses, such as reflux, arterio-venous micro-shunts, parietal, and connective tissue abnormalities, are described in the literature. The different hypotheses are discussed and put in a clinical perspective, in particular their therapeutic implications for phlebologists. Conclusion In conclusion, pathophysiology and risk factors of telangiectasias are still largely unknown, and a better understanding could improve treatment results and reduce recurrence.


Author(s):  
Tyler Safran ◽  
Hillary Nepon ◽  
Carrie K. Chu ◽  
Sebastian Winocour ◽  
Amanda Murphy ◽  
...  

AbstractOver 400,000 women in the United States alone will have breast implant surgery each year. Although capsular contracture represents the most common complication of breast implant surgery, surgeons continue to debate the precise etiology. General agreement exists concerning the inflammatory origin of capsular fibrosis, but the inciting events triggering the inflammatory cascade appear to be multifactorial, making it difficult to predict why one patient may develop capsular contracture while another will not. Accordingly, researchers have explored many different surgical, biomaterial, and medical therapies to address these multiple factors in an attempt to prevent and treat capsular contracture. In the current paper, we aim to inform the reader on the most up-to-date understanding of the pathophysiology, prevention, and treatment of capsular contracture.


2019 ◽  
Vol 6 ◽  
pp. 205435811983168 ◽  
Author(s):  
Rana Hassan ◽  
Ayub Akbari ◽  
Pierre A. Brown ◽  
Swapnil Hiremath ◽  
K. Scott Brimble ◽  
...  

2020 ◽  
Vol 48 (6) ◽  
pp. 030006052092787
Author(s):  
Anthony Papaconstantinou ◽  
Triantafyllia Koletsa ◽  
Efterpi Demiri ◽  
Kostantinos Gasteratos ◽  
Sofia-Eleni Tzorakoleftheraki ◽  
...  

Capsular contracture is one of the most distressing complications of breast implant use in both aesthetic and reconstructive plastic surgery procedures. This systematic review was performed to assess the effectiveness of all nonsurgical treatments for established capsular contracture.


Sign in / Sign up

Export Citation Format

Share Document